Evidence map›Paper›PMID 34200502›Full record

ReviewJournal of clinical medicine2021

The New Status of Parasitic Diseases in the COVID-19 Pandemic-Risk Factors or Protective Agents?

Kinga Głuchowska, Tomasz Dzieciątkowski, Aleksandra Sędzikowska, Anna Zawistowska-Deniziak, Daniel Młocicki

Open access · goldAbstract readReview
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Changes inThe Journal of international medical research · 2025
    Article
  3. Review
  4. Review
  5. Article
  6. A standardized combination ofFood & nutrition research · 2024
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Lung flukes of the genusParasitology · 2022
    Review
  12. Parasites Protect from Severe COVID-19. Myth or Reality?International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2022
    Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Kinga GłuchowskaDepartment of General Biology and Parasitology, Medical University of Warsaw, 02-004 Warsaw, Poland.
Tomasz DzieciątkowskiChair and Department of Medical Microbiology, Medical University of Warsaw, 02-004 Warsaw, Poland.
Aleksandra SędzikowskaDepartment of General Biology and Parasitology, Medical University of Warsaw, 02-004 Warsaw, Poland.ORCID 0000-0003-1721-5676
Anna Zawistowska-DeniziakWitold Stefański Institute of Parasitology, Polish Academy of Sciences, 00-818 Warsaw, Poland.ORCID 0000-0001-6990-9165
Daniel MłocickiDepartment of General Biology and Parasitology, Medical University of Warsaw, 02-004 Warsaw, Poland.ORCID 0000-0002-9762-9950
Medical University of Warsaw · PLWitold Stefański Institute of Parasitology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It is possible that parasites may influence the course of COVID-19 infection, as either risk factors or protective agents; as such, the current coronavirus pandemic may affect the diagnosis and prevention of parasitic disease, and its elimination programs. The present review highlights the similarity between the symptoms of human parasitoses and those of COVID-19 and discuss their mutual influence. The study evaluated selected human parasitoses with similar symptoms to COVID-19 and examined their potential influence on SARS-CoV-2 virus invasion. The available data suggest that at least several human parasitoses could result in misdiagnosis of COVID-19. Some disorders, such as malaria, schistosomiasis and soil-transmitted helminths, can increase the risk of severe infection with COVID-19. It is also suggested that recovery from parasitic disease can enhance the immune system and protect from COVID-19 infection. In addition, the COVID-19 pandemic has affected parasitic disease elimination programs in endemic regions and influenced the number of diagnoses of human parasitoses.

Indexed as

COVID-19diseasespandemicparasitesparasitosisSARS-CoV-2

Identifiers

PMID34200502
PMCPMC8200987
OpenAlexW3170449325

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.